Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Shares of VNDA Up 5.8% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Vanda Pharmaceut (NASDAQ:VNDA) on August 1st, 2019 at $15.82. In approximately 4 months, Vanda Pharmaceut has returned 5.79% as of today's recent price of $16.73.

VNDA : 17.11 (-0.23%)
SmarTrend Watching for Potential Pullback in Shares of Vanda Pharmaceut After 2.74% Gain

Vanda Pharmaceut (NASDAQ:VNDA) traded in a range yesterday that spanned from a low of $15.73 to a high of $16.10. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high...

VNDA : 17.11 (-0.23%)
Vanda Pharmaceuticals Announces Participation at November 2019 Investor Conferences

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in November 2019:

VNDA : 17.11 (-0.23%)
Top Ranked Value Stocks to Buy for November 14th

Top Ranked Value Stocks to Buy for November 14th

VNDA : 17.11 (-0.23%)
TNP : 3.58 (+3.17%)
QRTEA : 8.49 (-3.85%)
Coherus Bioscien has the Best Relative Performance in the Biotechnology Industry (CHRS , VNDA , ATRA , EPZM , RDUS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ATRA : 13.68 (-3.32%)
CHRS : 17.57 (-3.99%)
VNDA : 17.11 (-0.23%)
Vanda: 3Q Earnings Snapshot

WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported third-quarter net income of $100.4 million.

VNDA : 17.11 (-0.23%)
Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2019.

VNDA : 17.11 (-0.23%)
Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2019 and provide a general business overview, on Wednesday, November 6, 2019, after the market...

VNDA : 17.11 (-0.23%)
Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of Directors

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Anne Sempowski Ward has joined the company's Board of Directors, effective October 28, 2019. Following Ms. Ward's appointment, Vanda's...

VNDA : 17.11 (-0.23%)
Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs

Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced results of a comparative genomics study presented at the 2019 American Society of Human Genetics (ASHG) conference on October 19, 2019,...

VNDA : 17.11 (-0.23%)
Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enforcement

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve...

VNDA : 17.11 (-0.23%)
Look for Shares of Vanda Pharmaceut to Potentially Rebound after Yesterday's 2.16% Sell Off

Vanda Pharmaceut (NASDAQ:VNDA) traded in a range yesterday that spanned from a low of $12.68 to a high of $13.06. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

VNDA : 17.11 (-0.23%)
Spectrum Pharmac is Among the Companies in the Biotechnology Industry with the Best Relative Performance (SPPI , VNDA , MNTA , ESPR , CHRS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

MNTA : 16.85 (+1.57%)
SPPI : 9.50 (+0.32%)
VNDA : 17.11 (-0.23%)
Menlo (MNLO) Completes Enrollment in Phase II Pruritus Study

Menlo (MNLO) completes enrollment in the phase II study evaluating the safety and efficacy of once-daily oral serlopitant for the treatment of CPUO.

MRK : 88.75 (+0.09%)
VNDA : 17.11 (-0.23%)
ACOR : 1.70 (-7.10%)
MNLO : 4.13 (+3.77%)
SmarTrend Watching for Potential Pullback in Shares of Vanda Pharmaceut After 5.87% Gain

Vanda Pharmaceut (NASDAQ:VNDA) traded in a range yesterday that spanned from a low of $13.56 to a high of $14.07. Yesterday, the shares gained 5.9%, which took the trading range above the 3-day high...

VNDA : 17.11 (-0.23%)
Vanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administration to End Unnecessary and Scientifically Flawed Animal Toxicity Studies

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve...

VNDA : 17.11 (-0.23%)
Biotech Stock Roundup: CELG's Inrebic Gets FDA Nod, SRPT Suffers Setback & More

Key highlights of the past week include drug approvals, and other regulatory and pipeline news.

SRPT : 109.96 (-1.27%)
REGN : 368.34 (-0.44%)
CELG : 108.24 (+0.10%)
VNDA : 17.11 (-0.23%)
NBRV : 1.87 (-3.61%)
VRTX : 223.07 (-0.38%)
GILD : 65.93 (-1.23%)
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve...

VNDA : 17.11 (-0.23%)
Vanda Receives CRL From FDA for sNDA of Jet Lag Treatment

Vanda Pharmaceuticals (VNDA) receives a CRL from the FDA for the sNDA of Hetlioz (tasimelteon) to treat Jet Lag Disorder.

VNDA : 17.11 (-0.23%)
ACOR : 1.70 (-7.10%)
ACAD : 50.48 (+14.00%)
CSLLY : 95.1300 (-0.07%)
Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that on August 16 2019, it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) as part of its ongoing...

VNDA : 17.11 (-0.23%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.47 , AIZ +1.31 , SBAC +0.58 , SO +0.07 , WELL +0.28
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar